Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Shaanxi Panlong Pharmaceutical Group Limited By Share Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Shaanxi Panlong Pharmaceutical Group Limited By Share has a total shareholder equity of CN¥1.6B and total debt of CN¥150.3M, which brings its debt-to-equity ratio to 9.5%. Its total assets and total liabilities are CN¥2.2B and CN¥641.5M respectively. Shaanxi Panlong Pharmaceutical Group Limited By Share's EBIT is CN¥103.8M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥1.2B.
Anahtar bilgiler
9.5%
Borç/özkaynak oranı
CN¥150.34m
Borç
| Faiz karşılama oranı | -4.9x |
| Nakit | CN¥1.16b |
| Eşitlik | CN¥1.58b |
| Toplam yükümlülükler | CN¥641.52m |
| Toplam varlıklar | CN¥2.22b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding
Sep 30
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings
May 02Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%
Mar 06Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002864's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥443.5M).
Uzun Vadeli Yükümlülükler: 002864's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥198.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002864 has more cash than its total debt.
Borcun Azaltılması: 002864's debt to equity ratio has increased from 0% to 9.5% over the past 5 years.
Borç Kapsamı: 002864's debt is well covered by operating cash flow (103.4%).
Faiz Kapsamı: 002864 earns more interest than it pays, so coverage of interest payments is not a concern.